The limited number of radionuclides emitting alpha-particles and their limited availability is discussed. A new alpha-emitter 230U (T1/2 = 20.8 d, 100% a) is suggested and its preparation from thorium target bombarded by accelerated protons (via initial formation of 230Pa (T1/2 = 17.4 d, 8.4% decay to 230U)), or 4He is discussed. The Empire II model was used to calculate the excitation functions for the different products from bombardment of Th by protons. The calculated thick target yield for 230Pa is 0.6 mCi/mA . h, leading to about 24 mCi/mA . h of 230U or about 150 mCi/mA . h in the case of alpha-bombardment.
A new alpha-emitter for nuclear medicine: U-230 / Z.B. Alfassi, M.L. Bonardi, F. Groppi, E. Menapace. - In: JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY. - ISSN 0236-5731. - 270:2(2006 Nov), pp. 483-487. [10.1007/s10967-006-0344-x]
A new alpha-emitter for nuclear medicine: U-230
M.L. BonardiSecondo
;F. GroppiPenultimo
;
2006
Abstract
The limited number of radionuclides emitting alpha-particles and their limited availability is discussed. A new alpha-emitter 230U (T1/2 = 20.8 d, 100% a) is suggested and its preparation from thorium target bombarded by accelerated protons (via initial formation of 230Pa (T1/2 = 17.4 d, 8.4% decay to 230U)), or 4He is discussed. The Empire II model was used to calculate the excitation functions for the different products from bombardment of Th by protons. The calculated thick target yield for 230Pa is 0.6 mCi/mA . h, leading to about 24 mCi/mA . h of 230U or about 150 mCi/mA . h in the case of alpha-bombardment.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
